How to Help Your Patients Find Austedo in Stock: A Provider's Guide

Helping Your Patients Find Austedo: A Practical Provider's Guide

As a neurologist, psychiatrist, or movement disorder specialist prescribing Austedo (Deutetrabenazine), you know the drug works. What you may also know is that getting it into your patient's hands is often harder than it should be. Between specialty pharmacy requirements, prior authorization delays, and a cash price that exceeds $7,000 per month, your patients face real barriers to filling this prescription.

This guide offers a practical, step-by-step approach to helping your patients navigate the Austedo access landscape in 2026 — from locating stock to managing insurance and avoiding costly treatment interruptions.

Current Availability: What's Happening With Austedo

Austedo is not in formal shortage as of early 2026. Teva Pharmaceuticals continues to manufacture both the immediate-release (twice daily) and extended-release (Austedo XR, once daily) formulations.

The access challenges patients face are structural:

• Specialty pharmacy distribution — most retail pharmacies don't stock it
• Prior authorization requirements — nearly universal across payers
• High cost — $7,000 to $10,000/month cash price discourages pharmacy stocking
• No generic available — Teva is the sole manufacturer

For the full picture, see our clinical briefing on Austedo availability in 2026.

Why Patients Can't Find Austedo

Understanding the patient experience helps you intervene more effectively:

They Go to Their Usual Pharmacy

Most patients first try their regular chain pharmacy. For a specialty drug like Austedo, the pharmacy typically doesn't carry it and tells the patient they need to order it or use a specialty pharmacy. The patient calls your office frustrated and confused.

Insurance Creates Delays

Even after you submit a prescription, the insurance company may take 3 to 14 days to process a prior authorization. If step therapy is required, additional documentation showing previous treatment failure is needed. During this time, the patient is without medication.

They Don't Know About Specialty Pharmacies

Many patients have never used a specialty pharmacy and don't understand the different process — which may involve phone calls, enrollment, and home delivery rather than a quick pickup. Setting expectations early can reduce anxiety and prevent missed doses.

What Providers Can Do: 5 Practical Steps

Step 1: Submit Prior Authorization Early

Don't wait until the patient has been titrated to their maintenance dose. Begin the PA process as soon as you decide to prescribe Austedo. This gives the insurer time to process while you're titrating, so the patient's access is secured by the time they reach their therapeutic dose.

Keep pre-built PA templates with supporting documentation:

• Confirmed diagnosis (TD or HD chorea)
• AIMS score documentation (for TD)
• Prior treatment history and rationale for Austedo
• Relevant contraindications to alternatives

Step 2: Identify the Right Pharmacy Early

Ask the patient's insurance which specialty pharmacies are in-network for Austedo. Common specialty pharmacy partners include Accredo, Express Scripts Specialty, CVS Specialty, and OptumRx Specialty. Send the prescription directly to the appropriate specialty pharmacy to avoid delays.

You can also use Medfinder for Providers to check real-time pharmacy stock and identify locations that currently have Austedo available.

Step 3: Educate Patients on the Process

Set clear expectations at the first visit:

• "This medication goes through a specialty pharmacy — it won't be at your regular pharmacy."
• "Insurance will need to approve it first, which can take 1 to 2 weeks."
• "If you miss doses for more than a week, we'll need to restart at a lower dose."
• "Request refills at least 7 to 10 days early."

This framing prevents confusion and empowers patients to be proactive about their refills.

Step 4: Bridge Gaps With Samples

If you have Austedo samples available, use them strategically to bridge the gap between prescribing and insurance approval. This is especially important during initial titration, when the patient is most at risk of losing momentum due to access delays.

Contact your Teva representative about sample availability for your practice.

Step 5: Connect Patients With Financial Assistance

Cost is a major barrier. Make sure patients know about:

• Teva Copay Savings Program — may reduce copays to $0 for commercially insured patients
• Teva Cares Foundation — free medication for qualifying uninsured/underinsured patients
• Independent copay foundations — HealthWell Foundation, PAN Foundation, and others periodically offer grants for movement disorder medications

Assign a staff member to help patients with enrollment. For more, see how to help patients save money on Austedo.

Alternative Medications to Consider

If Austedo access is consistently problematic for a patient, consider these alternatives:

• Ingrezza (Valbenazine) — VMAT2 inhibitor approved for tardive dyskinesia; once-daily dosing; different specialty pharmacy network may offer better access for some patients
• Xenazine (Tetrabenazine) — VMAT2 inhibitor approved for Huntington's chorea; generic available, which may reduce cost and improve access; requires TID dosing

Note that concurrent use of multiple VMAT2 inhibitors is contraindicated. Patients transitioning between agents need appropriate washout guidance.

For detailed alternative comparisons, see alternatives to Austedo.

Workflow Tips for Your Practice

Integrating Austedo access management into your practice workflow can reduce the burden on both you and your patients:

Designate an Access Coordinator

Assign one team member to manage specialty medication prior authorizations, track PA timelines, and follow up with specialty pharmacies. This person becomes the patient's point of contact for access questions.

Track Re-Titration Risk

Flag patients in your EHR who are on Austedo. If a patient misses an appointment or you learn of a refill problem, proactively reach out. Remember: missing more than one week requires re-titration from 6 mg/day, which adds weeks to reaching therapeutic effect.

Use Medfinder Proactively

Medfinder for Providers allows your staff to check pharmacy stock before the patient leaves the office. This means you can direct patients to a pharmacy that has Austedo available — rather than sending them out to search on their own.

Document Everything

Thorough documentation of treatment rationale, AIMS scores, and prior treatment history not only supports PA approvals but also prepares you for peer-to-peer reviews if initial PAs are denied.

Final Thoughts

Austedo is an effective medication for tardive dyskinesia and Huntington's chorea, and your patients shouldn't have to fight to fill their prescriptions. By proactively managing the prior authorization process, connecting patients with the right pharmacies and financial assistance programs, and using tools like Medfinder, you can significantly improve your patients' experience and reduce treatment interruptions.

For related clinical resources, explore:

• Austedo shortage: what providers need to know in 2026
• Austedo drug interactions: what to avoid
• Austedo side effects: what to expect

This article is for informational purposes only and does not constitute medical advice. Clinical decisions should be made in consultation with the treating physician based on individual patient circumstances.